Cyclin-dependent kinase modulators and cancer therapy

M Gallorini, A Cataldi, V di Giacomo - BioDrugs, 2012 - Springer
The cell cycle of eukaryotic cells varies greatly from species to species and tissue to tissue.
Since an erroneous control of the cell cycle can have disastrous consequences for cellular …

Whether to target single or multiple CDKs for therapy? That is the question

J Węsierska‐Gądek, M Maurer… - Journal of cellular …, 2011 - Wiley Online Library
Complexes consisting of cyclin‐dependent kinases (CDKs) and their regulatory subunits
(the cyclins) control the progression of normal mammalian cells through the cell cycle …

Inhibition of aberrant cyclin-dependent kinase 5 activity attenuates isoflurane neurotoxicity in the developing brain

WY Wang, Y Luo, LJ Jia, SF Hu, XK Lou, SL Shen… - …, 2014 - Elsevier
Aberrant CDK5 activity is implicated in a number of neurodegenerative disorders. Isoflurane
exposure leads to neuronal apoptosis, and subsequent learning and memory defects in the …

In vitro antileukemic activity of novel adenosine derivatives bearing boron cluster modification

JD Żołnierczyk, AB Olejniczak, A Mieczkowski… - Bioorganic & Medicinal …, 2016 - Elsevier
A series of adenosine derivatives bearing a boron cluster were synthesized and evaluated
for their cytotoxicity against primary peripheral mononuclear cells from the blood of 17 …

The differences in thermal profiles between normal and leukemic cells exposed to anticancer drug evaluated by differential scanning calorimetry

P Góralski, M Rogalińska, JZ Błoński, E Pytel… - Journal of Thermal …, 2014 - Springer
Chronic lymphocytic leukemia (CLL) is a heterogenous disease with an imbalance between
apoptosis and cell proliferation. Therefore, the main goal in CLL therapy is to induce …

The impact of multi-targeted cyclin-dependent kinase inhibition in breast cancer cells: clinical implications

J Węsierska-Gądek, MP Kramer - Expert opinion on investigational …, 2011 - Taylor & Francis
Introduction: The progression of the mammalian cell cycle is driven by the transient
activation of complexes consisting of cyclins and cyclin-dependent kinases (CDKs). Loss of …

Reconstitution of human MCF‐7 breast cancer cells with caspase‐3 does not sensitize them to action of CDK inhibitors

J Węsierska‐Gądek, S Hackl… - Journal of cellular …, 2011 - Wiley Online Library
Human MCF‐7 breast cancer cells are resistant to pro‐apoptotic stimuli due to caspase‐3
inactivation. On the other hand, they should be sensitive to agents like selective …

Functional role of RNA polymerase II and P70 S6 kinase in KCl withdrawal-induced cerebellar granule neuron apoptosis

J Padmanabhan, KR Brown, A Padilla… - Journal of Biological …, 2015 - ASBMB
KCl withdrawal-induced apoptosis in cerebellar granule neurons is associated with aberrant
cell cycle activation, and treatment with cyclin-dependent kinase (Cdk) inhibitors protects …

Promotion of apoptosis in cancer cells by selective purine-derived pharmacological CDK inhibitors: one outcome, many mechanisms

J Wasierska-Gadek, M Maurer - Current pharmaceutical design, 2011 - ingentaconnect.com
The deregulation of apoptosis and the cell cycle are important steps in the onset of cancer,
giving cells unlimited reproductive potential and increasing their likelihood of survival. The …

Relationship between in vitro drug sensitivity and clinical response of patients to treatment in chronic lymphocytic leukemia

M Rogalińska, JZ Błoński… - international …, 2015 - spandidos-publications.com
To improve the efficacy of therapeutic options in chronic lymphocytic leukemia (CLL) an in
vitro system to determine the response of mononuclear blood cells from blood of patients …